Daniel Courchesne
Direktor/Vorstandsmitglied bei F3 Platform Biologics, Inc.
Profil
Daniel Courchesne is currently the Director at F3 Platform Biologics, Inc. He previously worked as a Principal at Royal Bank of Canada and National Bank of Canada.
He also held positions as President at Global One Financial, Inc. and Senior Vice President at Entaire Global Cos., Inc. Courchesne received his undergraduate degree from the University of Sherbrooke in 1987.
Aktive Positionen von Daniel Courchesne
Unternehmen | Position | Beginn |
---|---|---|
F3 Platform Biologics, Inc.
F3 Platform Biologics, Inc. BiotechnologyHealth Technology F3 Platform Biologics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of novel and practical biotechnology for human use. It handles research, clinical development, and commercialization of new indications surrounding amifostine, a compound that has been previously approved by FDA for indications involving the prevention and treatment of side effects related to cancer treatment and radiation therapy. The company was founded on June 5, 2018 and is headquartered in Atlanta, GA. | Direktor/Vorstandsmitglied | 04.10.2019 |
Ehemalige bekannte Positionen von Daniel Courchesne
Unternehmen | Position | Ende |
---|---|---|
Global One Financial, Inc. | Präsident | - |
ROYAL BANK OF CANADA | Corporate Officer/Principal | - |
NATIONAL BANK OF CANADA | Corporate Officer/Principal | - |
Entaire Global Cos., Inc.
Entaire Global Cos., Inc. Finance/Rental/LeasingFinance Entaire Global Cos., Inc. provided funding and financing solutions. Its services included asset based lending, financial strategies, and solutions. The company was founded by Jonathan Rosen and William R. Muirhead in 2001 and was headquartered in Atlanta, GA. | Corporate Officer/Principal | - |
Ausbildung von Daniel Courchesne
University of Sherbrooke | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
ROYAL BANK OF CANADA | Finance |
NATIONAL BANK OF CANADA | Finance |
Private Unternehmen | 3 |
---|---|
Global One Financial, Inc. | |
Entaire Global Cos., Inc.
Entaire Global Cos., Inc. Finance/Rental/LeasingFinance Entaire Global Cos., Inc. provided funding and financing solutions. Its services included asset based lending, financial strategies, and solutions. The company was founded by Jonathan Rosen and William R. Muirhead in 2001 and was headquartered in Atlanta, GA. | Finance |
F3 Platform Biologics, Inc.
F3 Platform Biologics, Inc. BiotechnologyHealth Technology F3 Platform Biologics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of novel and practical biotechnology for human use. It handles research, clinical development, and commercialization of new indications surrounding amifostine, a compound that has been previously approved by FDA for indications involving the prevention and treatment of side effects related to cancer treatment and radiation therapy. The company was founded on June 5, 2018 and is headquartered in Atlanta, GA. | Health Technology |